Panlong Pharmaceutical(002864.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Panlong Pharmaceutical
002864.SZ
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd was founded in 1997 and is based in Xi'an, China.
2.805 T
002864.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking61/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE5.15%C
    • Profit Margin7.80%B
    • Gross Margin54.85%B
  • Growth ScoreC
    • Revenue YoY9.79%B
    • Net Profit YoY-27.90%D
    • Total Assets YoY5.02%C
    • Net Assets YoY2.85%C
  • Cash ScoreB
    • Cash Flow Margin149.84%B
    • OCF YoY9.79%B
  • Operating ScoreC
    • Turnover0.47C
  • Debt ScoreB
    • Gearing Ratio29.67%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The A-shares opened lower and rose higher, with all three major indices turning positive. The chemical and electric grid sectors collectively surged, the Hang Seng Index fell over 1%, tech stocks continued to decline, and Shanghai silver dropped over 13%

    Wallstreetcn·
    SZ
    000554
    -0.52%
    SZ
    301111
    +0.92%
    SZ
    002493
    +0.08%
    Wallstreetcn·
    SZ
    000554
    -0.52%
    SZ
    301111
    +0.92%
    SZ
    002493
    +0.08%

    Chinese medicine stocks opened sharply higher, with Panlong Pharmaceutical and TY PHAR. hitting the daily limit, and Bio Valley and LSPG rising over 10%

    Wallstreetcn·
    SZ
    301111
    +0.92%
    SZ
    002864
    -0.89%
    SZ
    002728
    -2.42%
    Wallstreetcn·
    SZ
    301111
    +0.92%
    SZ
    002864
    -0.89%
    SZ
    002728
    -2.42%

    The three major A-share indices of Shanghai and Shenzhen opened lower by 0.9% to 1.2%, with oil and gold stocks weak, while traditional Chinese medicine stocks rose against the trend

    AASTOCKS·
    SH
    600938
    +1.57%
    SH
    600489
    -2.42%
    SH
    600547
    -1.98%
    AASTOCKS·
    SH
    600938
    +1.57%
    SH
    600489
    -2.42%
    SH
    600547
    -1.98%

    Zhitong A-share lock-up release overview | November 4

    Zhitong·
    SH
    600415
    +0.14%
    SZ
    002643
    +0.83%
    SZ
    002864
    -0.89%
    Zhitong·
    SH
    600415
    +0.14%
    SZ
    002643
    +0.83%
    SZ
    002864
    -0.89%

    Panlong Pharmaceutical: The net profit for the third quarter was 29.6707 million yuan, a decrease of 0.83%

    Zhitong·
    SZ
    002864
    -0.89%
    Zhitong·
    SZ
    002864
    -0.89%
    © 2026 Longbridge｜Disclaimer